Synthesis and cytotoxicity evaluation of 2-amino- and 2-hidroxy-3-ethoxycarbonyl-N-substituted-benzo[f]indole-4,9-dione derivatives.

Synthesis and cytotoxicity evaluation of 2-amino- and 2-hidroxy-3-ethoxycarbonyl-N-substituted-benzo[f]indole-4,9-dione derivatives.
复制标题

DOI:
10.1016/s0968-0896(03)00062-2
复制
发表时间:
2003-04
影响因子:
3.5
通讯作者:
Hyun-Jung Lee;M. Suh;Chong‐Ock Lee
Hyun-Jung Lee;M. Suh;Chong‐Ock Lee
中科院分区:
医学3区
文献类型:
--
作者:
Hyun-Jung Lee;M. Suh;Chong‐Ock Lee

文献摘要

被引文献

相似文献

2,3-二氯萘醌(Ⅰ)与氰乙酸乙酯或丙二酸二乙酯在不同条件下反应,得到2-氯-3-(α-氰基-α-乙氧羰基-甲基)-1,4-萘醌(A)或2-氯-3-(二乙氧羰基-甲基)-1,4-萘醌(B)。2-氨基-3-乙氧羰基-N-取代的-苯并[f]吲哚-4,9-二酮衍生物[A-(1-10)]和2-羟基-3-乙氧羰基-N-取代的-苯并[f]吲哚-4,9-二酮衍生物[B-(1-12)]分别由化合物A和B通过使用各种烷基胺和芳基胺制备。通过SR B(磺酰罗丹明B)测定法评价制备的化合物对以下肿瘤细胞系的细胞毒性活性:A459(人肺)、SK-0 V-3(人卵巢)、SK-MEL-2(人黑素瘤)、XF 498(人CNS)和HCT 15(人结肠)。所提及的许多衍生物对SK-OV-3和XF 498的细胞毒作用比依托泊苷更强。值得注意的是,2-氨基-3-乙氧羰基-N-(3-甲基-苯基)-苯并[f]吲哚-4,9-二酮(A-8)显示出对所有肿瘤细胞系的有效活性,特别是其对SK-0 V-3的细胞毒性作用远高于多柔比星。
Reaction between 2,3-dichloronaphthoquinone (I) and ethyl cyanoacetate or diethyl malonate under different conditions gave the starting materials, 2-chloro-3-(α-cyano-α-ethoxycarbonyl-methyl)-1,4-naphthoquinone (A) or 2-chloro-3-(diethoxycarbonyl-methyl)-1,4-naphthoquinone (B). The 2-amino-3-ethoxycarbonyl-N-substituted-benzo[f]indole-4,9-dione derivatives [A-(1–10)] and 2-hydroxy-3-ethoxycarbonyl-N-substituted-benzo[f]indole-4,9-dione derivatives [B-(1–12)] were prepared from compounds A and B, respectively, by using various alkyl-, and arylamines. The cytotoxic activities of the prepared compounds were evaluated by SRB (Sulforhodamine B) assay against the following tumor cell lines: A459 (human lung), SK-OV-3 (human ovarian), SK-MEL-2 (human melanoma), XF498 (human CNS), and HCT 15 (human colon). Many of the derivatives mentioned exhibited more potent cytotoxic effects against SK-OV-3 and XF498 than etoposide. Significantly, 2-amino-3-ethoxycarbonyl-N-(3-methyl-phenyl)-benzo[f]indole-4,9-dione (A-8) showed potent activity against all tumor cell lines, and in particular, its cytotoxic effect against SK-OV-3 was much higher than doxorubicin.